95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Oh-Hyun Lee1†
Yongcheol Kim1†Nak-Hoon Son2,3Deok-Kyu Cho1
Jung-Sun Kim4
Byeong-Keuk Kim4
Donghoon Choi1
Myeong-Ki Hong4
Myung Ho Jeong5*Yangsoo Jang6 on behalf of the KAMIR-NIH Investigators- 1Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea
- 2Data Science Team (Biostatistician), Center for Digital Health, Yongin Severance Hospital, Yongin-si, South Korea
- 3Department of Statistics, Keimyung University, Daegu, South Korea
- 4Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea
- 5Chonnam National University Hospital and Medical School, Gwangju, South Korea
- 6Department of Cardiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, South Korea
A corrigendum on
Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk
by Lee, O.-H., Kim, Y., Son, N.-H., Cho, D.-K., Kim, J.-S., Kim, B.-K., Choi, D., Hong, M.-K., Jeong, M. H., and Jang, Y. (2022). Front. Cardiovasc. Med. 9:880351. doi: 10.3389/fcvm.2022.880351
In the published article, there was an error in affiliation 5. Instead of “Chonnam National University Hospital, Gwangju, South Korea,” it should be “Chonnam National University Hospital and Medical School, Gwangju, South Korea.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ST-segment elevation myocardial infarction, drug-eluting stent, percutaneous coronary intervention (PCI), target lesion failure, high risk factor
Citation: Lee O-H, Kim Y, Son N-H, Cho D-K, Kim J-S, Kim B-K, Choi D, Hong M-K, Jeong MH and Jang Y (2022) Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk. Front. Cardiovasc. Med. 9:952331. doi: 10.3389/fcvm.2022.952331
Received: 25 May 2022; Accepted: 11 August 2022;
Published: 24 August 2022.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2022 Lee, Kim, Son, Cho, Kim, Kim, Choi, Hong, Jeong and Jang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Myung Ho Jeong, bXl1bmdob0BjaG9sbGlhbi5uZXQ=
†These authors have contributed equally to this work